Analysis of the Availability of Iron Supplement Tablets (TTD) and Tetanus-Diphtheria (Td) Vaccines for Maternal Services at the East Seram District Health Office in 2023

Abstrak

Analysis of the Availability of Iron-Folic Acid (IFA) Tablets and Tetanus-Diphtheria (TD) Vaccines for Maternal Health Services at the East Seram District Health Office in 2023 Objective: This study aims to assess the availability of Iron-Folic Acid (IFA) tablets and Tetanus-Diphtheria (TD) vaccines for maternal health services, identify the causes of unavailability, and evaluate the supply mechanism to ensure effective and efficient management. Methods: The study employed a document review approach, analyzing the 2023 Government Agency Performance Report (LKIP), Regulation of the Minister of Health No. 4 of 2019, stock opname reports, stock cards, and handover documents (BAST) for drugs and vaccines. In-depth interviews were conducted with four key informants: the pharmaceutical sub-coordinator, the program drug manager, the maternal and child health (MCH) program manager, and the head of the pharmaceutical installation. Results: The availability of IFA tablets and TD vaccines was insufficient to meet maternal service needs, with shortages of 98,880 IFA tablets (33.33%) and 30 vials of TD vaccine (10%). The main causes of unavailability included expired drugs, stockouts due to delayed provincial distribution, and inaccuracies in the supply planning mechanism. Conclusion: The study concludes that the availability of IFA tablets and TD vaccines for maternal health services at the East Seram District Health Office in 2023 was inadequate, highlighting the need for improved supply management and planning to meet service targets.